Medclair AB (NGM:MCLR) ROE % Adjusted to Book Value : -7.41% (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Medclair AB ROE % Adjusted to Book Value?

Medclair AB's ROE % for the quarter that ended in Sep. 2024 was -21.86%. Medclair AB's PB Ratio for the quarter that ended in Sep. 2024 was 2.95. Medclair AB's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -7.41%.

Medclair AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Medclair AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medclair AB ROE % Adjusted to Book Value Chart

Medclair AB Annual Data

Trend

Apr15

Apr16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-18.26

-4.48

-6.98

-4.64

-1.96

Medclair AB Quarterly Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															2.14	-5.62	-0.66	17.80	-7.41

Competitive Comparison of Medclair AB's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Medclair AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medclair AB's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medclair AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Medclair AB's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Medclair AB ROE % Adjusted to Book Value Calculation

Medclair AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-5.42%	/	2.77
	=	-1.96%

Medclair AB's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-21.86%	/	2.95
	=	-7.41%

Medclair AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Medclair AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Medclair AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medclair AB (NGM:MCLR) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Box 3113, Stockholm, SWE, 103 62

Website

https://www.medclair.com

Medclair AB operates in healthcare industry. The company has two units: Central Destruction Unit (CDU) and Mobile Destruction Unit (MDU) decomposes up to 99% of the nitrous oxide entering the unit, transforming it to nitrogen (N2) och oxygen (O2). It also provide solutions for various N2O methods such as double mask, single mask, mouthpiece, or free flow, which ensures a safe work environment for healthcare professionals.

Medclair AB Headlines

No Headlines